These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6088041)

  • 1. Selection and rejection of retrovirus-expressing tumor cells from a heterogeneous murine leukemia virus-infected cell population.
    Zbar B; Terata N; Nagai A; Tanio Y; Hovis J
    Cancer Res; 1984 Oct; 44(10):4622-9. PubMed ID: 6088041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection of retrovirus-infected tumor cells in guinea pigs: effect on bystander tumor cells.
    Nagai A; Zbar B; Terata N; Hovis J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5783-8. PubMed ID: 6315216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor rejection mediated by an amphotropic murine leukemia virus.
    Zbar B; Nagai A; Terata N; Hovis J
    Cancer Res; 1983 Jan; 43(1):46-53. PubMed ID: 6182993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic variants isolated from a mutagen-treated guinea pig fibrosarcoma.
    Zbar B; Sukumar S; Tanio Y; Terata N; Hovis J
    Cancer Res; 1984 Nov; 44(11):5079-85. PubMed ID: 6488168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-clonal interactions in the generation of proviral gene deletion variants.
    Zbar B; Tanio Y
    J Natl Cancer Inst; 1987 Aug; 79(2):383-8. PubMed ID: 3474468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
    J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo immunologic selection of proviral gene deletion variants from a nonproducer clone.
    Tanio Y; Talmadge C; Dekaban G; Hovis J; Ohanian SH; Zbar B
    J Natl Cancer Inst; 1986 Sep; 77(3):767-75. PubMed ID: 3018345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
    Iglehart JD; Ward EC; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):117-22. PubMed ID: 6942182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
    Iglehart JD; Ward EC; Thiel K; Huper G; Geier SS; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):107-15. PubMed ID: 6942181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.
    Hosokawa M; Okayasu T; Ikeda K; Katoh H; Suzuki Y; Kobayashi H
    Cancer Res; 1983 May; 43(5):2301-5. PubMed ID: 6831454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2-responsive T cells and prevents the development of unresponsiveness.
    Zier KS; Salvadori S; Cronin KC; Gansbacher B
    Cancer Gene Ther; 1994 Mar; 1(1):43-50. PubMed ID: 7621237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of tumor associated antigen expression during the regression phase of xenogenized tumor cell growth in vivo.
    Shibata T; Micallef M; Chiba I; Arisue M; Hosokawa M; Okada F; Takeichi N; Kobayashi H
    Anticancer Res; 1997; 17(3C):2135-40. PubMed ID: 9216677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages.
    Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L
    J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.